Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 102 Records) |
| Query Trace: Primary Myelofibrosis and CALR[original query] |
|---|
| [Clinical impact of gene mutations on myeloproliferative neoplasms in Japan]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2021 9 62 (8): 1060-1069. Morishita So |
| Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN). International journal of environmental research and public health 2021 Jul 18 (14): . Zulkeflee Razan Hayati, Zulkafli Zefarina, Johan Muhammad Farid, Husin Azlan, Islam Md Asiful, Hassan Rosli |
| JAK2, CALR, and MPL Mutation Profiles in BCR-ABL Negative Myeloproliferative Neoplasms, a Referral Center Experience in the Middle East. Iranian journal of pathology 2021 5 16 (2): 190-194. Safavi Moeinadin, Monabati Ahmad, Safaei Akbar, Mirtalebi Maryam Sadat, Faghih Masoum |
| Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era. Journal of clinical medicine 2021 Mar 10 (5): . Lee Jong-Mi, Lee Howon, Eom Ki-Seong, Lee Sung-Eun, Kim Myungshin, Kim Yongg |
| Analysis of Common Driver Mutations in Philadelphia-Negative Myeloproliferative Neoplasms. Clinical lymphoma, myeloma & leukemia 2021 4 21 (7): 483-488. Alshemmari Salem H, Rajan Reshmi, Ameen Reem, Almazyad Mazy |
| Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study. Frontiers in oncology 2021 4 11 637116. Cattaneo Daniele, Croci Giorgio Alberto, Bucelli Cristina, Tabano Silvia, Cannone Marta Giulia, Gaudioso Gabriella, Barbanti Maria Chiara, Barbullushi Kordelia, Bianchi Paola, Fermo Elisa, Fabris Sonia, Baldini Luca, Gianelli Umberto, Iurlo Alessand |
| Mutation Profile in BCR-ABL1-Negative Myeloproliferative Neoplasms: A Single-Center Experience From India. Hematology/oncology and stem cell therapy 2021 3 15 (2): 13-20. Maddali Madhavi, Kulkarni Uday Prakash, Ravindra Niveditha, Arunachalam Arun Kumar, Venkatraman Arvind, Lionel Sharon, Manipadam Marie Therese, Devasia Anup J, Korula Anu, Fouzia N A, Abraham Aby, Srivastava Alok, George Biju, Balasubramanian Poonkuzhali, Mathews Vikr |
| VEGFA rs3025020 Polymorphism Contributes to CALR -Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis. TH open : companion journal to thrombosis and haemostasis 2021 11 5 (4): e513-e520. Villani Laura, Rosti Vittorio, Massa Margherita, Campanelli Rita, Catarsi Paolo, Carolei Adriana, Abbà Carlotta, de Silvstri Annalisa, Gale Robert Peter, Barosi Giovan |
| The different variant allele frequencies of type I/type II mutations and the distinct molecular landscapes in CALR-mutant essential thrombocythaemia and primary myelofibrosis. Hematology (Amsterdam, Netherlands) 2022 8 27 (1): 902-908. Pan Yuxia, Wang Xingzhe, Wen Shupeng, Liu Xiaojun, Yang Lin, Luo Jianm |
| The differences of hemogram, myelogram, and driver gene mutations in classic myeloproliferative neoplasms. Blood cells, molecules & diseases 2022 8 97 102698. Wang Jin, Zhang Jin, Huang Jinjin, Mei Yu, Hong Zhen |
| Targeted sequencing of candidate gene regions for myelofibrosis in dogs. Journal of veterinary internal medicine 2022 7 36 (4): 1237-1247. Campbell Amelia G, Seelig Davis M, Beckman Joan D, Minor Katie M, Heinrich Daniel A, Friedenberg Steven G, Modiano Jaime F, Furrow E |
| Study of CALR, MPL, and c-kit Gene Mutations in Thai Patients with JAK2 V617F Negative Myeloproliferative Neoplasms. Asian Pacific journal of cancer prevention : APJCP 2022 5 23 (5): 1671-1678. Wiriyaukaradecha Kriangpol, Nimsanor Supanee, Tantirukdham Nithiphut, Tongsom Jin, Bunyoo Chakrit, Soonklang Kamonwan, Sritana Narongrit, Auewarakul Chira |
| Clonal Megakaryocyte Dysplasia with Isolated Thrombocytosis Is a Distinct Myeloproliferative Neoplasm Phenotype. Acta haematologica 2022 11 146 (1): 14-25. Barosi Giovanni, Campanelli Rita, Massa Margherita, Catarsi Paolo, Carolei Adriana, Abbà Carlotta, Villani Laura, Magrini Umberto, Gregato Giuliana, Bertolini Francesco, de Silvestri Annalisa, Gale Robert Peter, Rosti Vittor |
| Effects of CALR-Mutant Type and Burden on the Phenotype of Myeloproliferative Neoplasms. Diagnostics (Basel, Switzerland) 2022 11 12 (11): . Kim Hyun-Young, Han Yujin, Jang Jun Ho, Jung Chul Won, Kim Sun-Hee, Kim Hee-J |
| The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis. Frontiers in oncology 2023 8 13 1190305. Helna Pettersson, Jenni Adamsson, Peter Johansson, Staffan Nilsson, Lars Palmqvist, Björn Andréasson, Julia A |
| Case report: Application of targeted NGS for the detection of non-canonical driver variants in MPN. Frontiers in genetics 2023 7 14 1198834. Jin Zhang, Kefeng Shen, Min Xiao, Jinjin Huang, Jin Wang, Yaqin Wang, Zhenya Ho |
| High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis. Journal of applied genetics 2023 7 . Zuzanna Kandu?a, Micha? Janowski, Barbara Wi?ckowska, Edyta Paczkowska, Aleksandra Mroczkowska-B?karciak, Marta Sobas, Krzysztof Lewandows |
| [Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 6 44 (4): 276-283. X Yan, T J Qin, B Li, S Q Qu, L J Pan, F H Li, N N Liu, Z J Xiao, Z F |
| JAK2/STAT5 Pathway Mutation Frequencies in South African BCR/ABL Negative MPN Patients. Hematology/oncology and stem cell therapy 2023 4 16 (3): 303-314. Shires Karen L, Rust Adriana J, Harryparsad Rushil, Coburn Justin A, Gopie Ruth |
| Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis. Advances in experimental medicine and biology 2023 4 1408 273-290. Sun?ica Kapor, Sanja Mom?ilovi?, Slobodan Kapor, Slavko Mojsilovi?, Milica Radojkovi?, Milica Apostolovi?, Branka Filipovi?, Mirjana Goti?, Vladan ?oki?, Juan F Santiban |
| Comparison of Clinical and Molecular Features Between Patients With Essential Thrombocythemia and Early/Prefibrotic Primary Myelofibrosis Presenting With Thrombocytosis in Taiwan. American journal of clinical pathology 2023 3 . Kuo Ming-Chung, Chuang Wen-Yu, Chang Hung, Lin Tung-Huei, Wu Jin-Hou, Lin Tung-Liang, Ou Che-Wei, Hung Yu-Shin, Huang Ting-Yu, Huang Ying-Jung, Wang Po-Nan, Shih Lee-Yu |
| Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL. Technology in cancer research & treatment 2023 2 22 15330338231154092. Wang Yan, Ran Fei, Lin Jin, Zhang Jing, Ma D |
| The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience. Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 202-209. Basim Najm Maysam, Jalal Sana Dlawar, Getta Hisham Ar |
| Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 36 (3): 100016. Al-Ghamdi Yahya A, Lake Jonathan, Bagg Adam, Thakral Beenu, Wang Sa A, Bueso-Ramos Carlos, Masarova Lucia, Verstovsek Srdan, Rogers Heesun J, Hsi Eric D, Gralewski Jonathon H, Chabot-Richards Devon, George Tracy I, Rets Anton, Hasserjian Robert P, Weinberg Olga K, Parilla Megan, Arber Daniel A, Padilla Osvaldo, Orazi Attilio, Tam Way |
| STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy 2023 12 . Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jia |
| JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms. Colombia medica (Cali, Colombia) 2023 12 54 (3): e2035353. Ana Isabel Giraldo-Rincón, Sara Naranjo Molina, Natalia Gomez-Lopera, Daniel Aguirre Acevedo, Andrea Ucroz Benavidez, Kenny Gálvez Cárdenas, Francisco Cuellar Ambrosí, Jose Domingo Torres, Sigifredo Ospina, Katherine Palacio, Lina Gaviria Jaramillo, Carlos Mario Muñeton, Gonzalo Vasquez Palac |
| Leukemic conversion involving RAS mutations of type 1 CALR-mutated primary myelofibrosis in a patient treated for HCV cirrhosis: a case report. Frontiers in oncology 2023 10 13 1266996. Petruta Gurban, Cristina Mambet, Anca Botezatu, Laura G Necula, Ana I Neagu, Lilia Matei, Ioana M Pitica, Saviana Nedeianu, Mihaela Chivu-Economescu, Coralia Bleotu, Marius Ataman, Gabriela Mocanu, Carmen Saguna, Anca G Pavel, Danae Stambouli, Elise Sepulchre, Gabriela Anton, Carmen C Diaconu, Stefan N Constantines |
| Prevalence and clinicopathological features of driver gene mutations profile in BCR: ABL1 negative classical myeloproliferative neoplasm-A single-center study from North India. Indian journal of pathology & microbiology 2024 5 . Khaliqur Rahman, Seema Biswas, Akhilesh Sharma, Kusum Gupta, Dinesh Chandra, Manish K Singh, Ruchi Gupta, Ashish Mishra, Sanjeev Kumar, Anshul Gupta, Faheema Hasan, Soniya Nityanand, Rajesh Kahsy |
| Risk factors for ischemic stroke in patients with Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2024 5 125 159-166. Shirong Wen, Wenxiao Zhang, Yiping Fei, Ke Guan, Hui Zhao, Peng Song, Xiangmei Ye, Yujun P |
| Molecular Profile of BCR-ABL1 Negative Myeloproliferative Neoplasm in a Moroccan Population. Asian Pacific journal of cancer prevention : APJCP 2024 11 25 (11): 4013-4025. Somda Georgina Charlène Soro, Ghita Amalou, Sara Benchikh, Adil El Hamouchi, Hicham Charoute, Mourad Oukheda, Benani Bennani Abdelouaheb, Rachid Saile, Halima Lebrazi, Sanaa Nassereddi |
- Page last reviewed:Feb 1, 2024
- Content source: